Search

Your search keyword '"Hirtz C"' showing total 213 results

Search Constraints

Start Over You searched for: Author "Hirtz C" Remove constraint Author: "Hirtz C"
213 results on '"Hirtz C"'

Search Results

4. Multivariate Analysis of RNA Chemistry Marks Uncovers Epitranscriptomics-Based Biomarker Signature for Adult Diffuse Glioma Diagnostics

11. Tau protein in cerebrospinal fluid: a novel biomarker of the time of death?

12. Analytical comparison of ELISA and mass spectrometry for quantification of serum hepcidin in critically ill patients

13. Cytokines as new biomarkers of skin wound vitality

14. Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?

18. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

21. Towards a routine application of Top-Down approaches for label-free discovery workflows

22. Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis.

26. Strain effect on extracellular laccase activities from <italic>Botrytis cinerea</italic>.

27. Complejidad del proteoma de la saliva humana

28. Epidermal growth factor: a probable oral and digestive health protector

29. The effect of environmental salinity on the proteome of the sea bass (Dicentrarchus labrax L.)

31. ENDOMETRIOSIS, ENDOMETRIUM, IMPLANTATION AND FALLOPIAN TUBE

34. 35th Annual Meeting of the European Association for the Study of Diabetes

35. 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999

36. Exocytosis and protein secretion in Trypanosoma

37. Proteins and proteolysis in pre-term and term human milk and possible implications for infant formulae

38. Dual CRALBP isoforms unveiled: iPSC-derived retinal modelling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy.

39. Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease.

40. A candidate reference measurement procedure for the quantification of α-synuclein in cerebrospinal fluid using an SI traceable primary calibrator and multiple reaction monitoring.

41. Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-up.

42. Inherited mitochondrial dysfunction triggered by OPA1 mutation impacts the sensory innervation fibre identity, functionality and regenerative potential in the cornea.

43. Enabling population protein dynamics through Bayesian modeling.

44. Modeling the Simultaneous Dynamics of Proteins in Blood Plasma and the Cerebrospinal Fluid in Human In Vivo .

45. Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells.

46. Post-polio syndrome is not a dysimmune condition.

47. Inflammation biomarkers in the intracranial blood are associated with outcome in patients with ischemic stroke.

48. Increasing the sensitivity of Simoa via bead count reduction facilitates the quantification of pTau-181 in dried plasma spots.

49. Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation.

50. A sensitive high-resolution mass spectrometry method for quantifying intact M-protein light chains in patients with multiple myeloma.

Catalog

Books, media, physical & digital resources